KMTSKestra Medical Technologies, Ltd.

$26.95+8.0% 1Y

The financials

Kestra Medical Technologies, Ltd. by the numbers

Kestra Medical Technologies, Ltd. (KMTS) reported revenue of $31M in Q1 2027 (quarter ended Jul 31, 2026), up 60% from the same quarter a year earlier. That came with a gross margin of 56% and net loss of $44M. For the full year FY2026, revenue was $95M (+59% year on year) and net income −$132M. The next results filing is expected around Dec 10, 2026, the same week as a year ago.

Kestra Medical Technologies, Ltd. income statement, Q1 2027 against the same quarter a year earlier
Income statementQ1 2027Q1 2026Change
Revenue$31M$19M+60%
Gross profit$17M$8.9M+98%
Operating income−$38M−$29Mn/a
Net income−$44M−$26Mn/a
Diluted EPS−$0.75−$0.50n/a